Sandugash Yerkenova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sandugash Yerkenova has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Aknur Turgumbayeva
Al-Farabi Kazakh National University, Almaty, Kazakhstan
3 shared publications - Alla Mireeva
Department of General Medical Practice No. 2, School of Medicine, S.D. Asfendiyarov Kazakh National Medical University, 94 Tole-bi Str., Almaty 050012, Kazakhstan
2 shared publications - Alla Mireeva
Department of Public Health, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan
2 shared publications - Almagul Kurmanova
Faculty of Medicine and Healthcare, Al-Farabi Kazakh National University, 71 Al-Farabi Ave., 050040 Almaty, Kazakhstan
2 shared publications - Galiya Alikeyeva
Department of Public Health, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan
2 shared publications - Gulnara Kalibekova
Department of Science and Consulting, Kazakhstan Medical University “Higher School of Public Health”, Almaty 050044, Kazakhstan
2 shared publications
Latest Publications
- Open Access
Acute Intestinal Infections in Children Aged 1–5 in Developed and Developing Countries
Acute intestinal infections remain one of the leading causes of morbidity among children under five years of age and represent an important public health challenge in both developed and developing countries. Although these infections often share similar clinical manifestations, their etiological structure, severity, diagnostic accessibility, treatment approaches, and prevention strategies differ considerably depending on socioeconomic conditions, sanitation, healthcare infrastructure, and vaccination coverage. Aim: This review aims to summarize current data on the epidemiology, etiology, clinical presentation, diagnosis, treatment, and prevention of acute intestinal infections in children aged 1–5 years, as well as to provide a comparative analysis of approaches in countries with different income levels. Methods: A review of scientific literature focused on acute intestinal infections in young children was conducted. Source selection included full-text assessment. The extracted data were summarized descriptively according to pathogen groups: viral, bacterial, and protozoal infections. A PRISMA flow diagram was used to present the source selection process. Results: The reviewed literature indicates that viral pathogens, particularly rotavirus and norovirus, are among the leading causes of acute gastroenteritis in children under five years of age. According to Global Burden of Disease 2021 estimates, approximately 392.8 million diarrhoeal episodes and 0.34 million deaths occurred among children under five years of age globally in 2021, with mortality disproportionately concentrated in sub-Saharan Africa and South Asia. Bacterial infections, including Shigella and diarrheagenic Escherichia coli, are less frequent but are more often associated with invasive disease, severe diarrhea, and systemic complications. Protozoal infections, including Giardia lamblia, may contribute to prolonged diarrhea, especially in children with malnutrition or weakened immune status. Substantial regional differences were identified in pathogen distribution, antimicrobial resistance, diagnostic capacity, access to healthcare, and vaccination coverage. In developing countries, the disease burden remains strongly associated with limited access to safe water, sanitation, timely diagnosis, and appropriate medical care, whereas in developed countries acute intestinal infections more commonly contribute to outbreaks, emergency department visits, and hospitalizations. Conclusions: Acute intestinal infections in children aged 1–5 years remain an important global health burden with substantial regional disparities. Effective prevention and control require context-specific strategies combining high vaccination coverage, improved water, sanitation and hygiene, timely pathogen-specific diagnosis, rational antimicrobial use, and strengthened surveillance, with particular priority given to high-burden and resource-limited settings.
Open AccessAcute Intestinal Infections in Children Aged 1–5 in Developed and Developing Countries
Acute intestinal infections remain one of the leading causes of morbidity among children under five years of age and represent an important public health challenge in both developed and developing countries. Although these infections often share similar clinical manifestations, their etiological structure, severity, diagnostic accessibility, treatment approaches, and prevention strategies differ considerably depending on socioeconomic conditions, sanitation, healthcare infrastructure, and vaccination coverage. Aim: This review aims to summarize current data on the epidemiology, etiology, clinical presentation, diagnosis, treatment, and prevention of acute intestinal infections in children aged 1–5 years, as well as to provide a comparative analysis of approaches in countries with different income levels. Methods: A review of scientific literature focused on acute intestinal infections in young children was conducted. Source selection included full-text assessment. The extracted data were summarized descriptively according to pathogen groups: viral, bacterial, and protozoal infections. A PRISMA flow diagram was used to present the source selection process. Results: The reviewed literature indicates that viral pathogens, particularly rotavirus and norovirus, are among the leading causes of acute gastroenteritis in children under five years of age. According to Global Burden of Disease 2021 estimates, approximately 392.8 million diarrhoeal episodes and 0.34 million deaths occurred among children under five years of age globally in 2021, with mortality disproportionately concentrated in sub-Saharan Africa and South Asia. Bacterial infections, including Shigella and diarrheagenic Escherichia coli, are less frequent but are more often associated with invasive disease, severe diarrhea, and systemic complications. Protozoal infections, including Giardia lamblia, may contribute to prolonged diarrhea, especially in children with malnutrition or weakened immune status. Substantial regional differences were identified in pathogen distribution, antimicrobial resistance, diagnostic capacity, access to healthcare, and vaccination coverage. In developing countries, the disease burden remains strongly associated with limited access to safe water, sanitation, timely diagnosis, and appropriate medical care, whereas in developed countries acute intestinal infections more commonly contribute to outbreaks, emergency department visits, and hospitalizations. Conclusions: Acute intestinal infections in children aged 1–5 years remain an important global health burden with substantial regional disparities. Effective prevention and control require context-specific strategies combining high vaccination coverage, improved water, sanitation and hygiene, timely pathogen-specific diagnosis, rational antimicrobial use, and strengthened surveillance, with particular priority given to high-burden and resource-limited settings.
- Open Access
Infantile Spasms (West Syndrome): Integrating Genetic, Neurotrophic, and Hormonal Mechanisms Toward Precision Therapy
Background and Objectives: Infantile spasms (ISs), or West syndrome (WS), represent an early-onset epileptic encephalopathy in which diverse structural, genetic, metabolic, infectious, and neurocutaneous conditions converge on a shared pattern of hypsarrhythmia, clustered spasms, and later developmental impairment. Growing use of genomic diagnostics has revealed that variants in STXBP1, KCNQ2, GRIN2A, GRIN2B, and TSC-related genes are more common than previously recognized and can be linked to partially actionable pathways. This review aimed to synthesize current evidence on the multifactorial etiology, network-based pathogenesis, and evolving targeted therapies for ISs, with particular attention to TSC-related forms. Materials and Methods: A structured narrative review was undertaken of publications from 1990 to 2025 in PubMed, Scopus, Web of Science, and Embase using terms related to ISs, WS, genetics, mTOR, ACTH, vigabatrin, ketogenic diet, and precision therapies. Authoritative guidance from ILAE and AAN was incorporated. Clinical, molecular, and therapeutic data were grouped under etiological, pathogenetic, and management domains. Results: Structural causes remained the largest group, but combined genetic, genetic–structural, and metabolic etiologies accounted for about one third of contemporary cohorts. Early network disruption involving cortex, thalamus, basal ganglia, and brainstem, together with imbalances in NGF, BDNF, and IGF-1, explained why distinct primary insults produce a uniform electroclinical phenotype. Early treatment with ACTH or high dose prednisolone, with or without vigabatrin, was consistently associated with higher electroclinical remission and better developmental outcome. Everolimus and related mTOR inhibitors showed benefit in TSC-associated ISs, while agents directed at NMDA receptors or KCNQ channels are emerging for genotype defined subgroups. Conclusions: ISs should be approached as a heterogeneous but mechanistically convergent disorder in which rapid diagnosis, parallel genetic testing, and early disease modifying therapy improve prognosis. Integration of molecular profiling with standardized outcome monitoring is likely to move management from symptomatic seizure control to pathway-specific intervention.
Open AccessInfantile Spasms (West Syndrome): Integrating Genetic, Neurotrophic, and Hormonal Mechanisms Toward Precision Therapy
Background and Objectives: Infantile spasms (ISs), or West syndrome (WS), represent an early-onset epileptic encephalopathy in which diverse structural, genetic, metabolic, infectious, and neurocutaneous conditions converge on a shared pattern of hypsarrhythmia, clustered spasms, and later developmental impairment. Growing use of genomic diagnostics has revealed that variants in STXBP1, KCNQ2, GRIN2A, GRIN2B, and TSC-related genes are more common than previously recognized and can be linked to partially actionable pathways. This review aimed to synthesize current evidence on the multifactorial etiology, network-based pathogenesis, and evolving targeted therapies for ISs, with particular attention to TSC-related forms. Materials and Methods: A structured narrative review was undertaken of publications from 1990 to 2025 in PubMed, Scopus, Web of Science, and Embase using terms related to ISs, WS, genetics, mTOR, ACTH, vigabatrin, ketogenic diet, and precision therapies. Authoritative guidance from ILAE and AAN was incorporated. Clinical, molecular, and therapeutic data were grouped under etiological, pathogenetic, and management domains. Results: Structural causes remained the largest group, but combined genetic, genetic–structural, and metabolic etiologies accounted for about one third of contemporary cohorts. Early network disruption involving cortex, thalamus, basal ganglia, and brainstem, together with imbalances in NGF, BDNF, and IGF-1, explained why distinct primary insults produce a uniform electroclinical phenotype. Early treatment with ACTH or high dose prednisolone, with or without vigabatrin, was consistently associated with higher electroclinical remission and better developmental outcome. Everolimus and related mTOR inhibitors showed benefit in TSC-associated ISs, while agents directed at NMDA receptors or KCNQ channels are emerging for genotype defined subgroups. Conclusions: ISs should be approached as a heterogeneous but mechanistically convergent disorder in which rapid diagnosis, parallel genetic testing, and early disease modifying therapy improve prognosis. Integration of molecular profiling with standardized outcome monitoring is likely to move management from symptomatic seizure control to pathway-specific intervention.
- Open Access
- 17 June 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (12) , 1536
Structural and Hormonal Changes in Reproductive-Age Women Post-COVID-19: A Cross-Sectional Ultrasound and Biochemical Study
Background/Objectives: The long-term impact of COVID-19 on female reproductive health remains poorly understood. This study aimed to assess structural and endocrine alterations in women of reproductive age who had recovered from SARS-CoV-2 infection compared to uninfected controls. Materials and Methods: A total of 150 women aged 18–45 years were enrolled in a comparative study: 75 with a confirmed history of COVID-19 and 75 without one. All participants underwent ultrasound examinations of their pelvic organs and mammary glands, along with laboratory assessment of reproductive hormones and inflammatory markers. Results: Structural abnormalities in the pelvic organs were observed in 53.5% of the post-COVID-19 group versus 12.0% of the control group (p < 0.001), with oophoritis showing a statistically significant association (OR = 11.38; 95% CI: 1.42–91.36; p = 0.009). Non-significant but elevated frequencies were also found for uterine fibroids and breast cysts. Biochemically, post-COVID-19 participants demonstrated higher serum ferritin, estradiol, and fibrinogen levels, along with lower TSH and AMH levels, suggesting potential endocrine disruption and persistent inflammation. Conclusions: Women with a history of COVID-19 may be at increased risk of developing structural and hormonal abnormalities, highlighting the importance of post-infection gynecological and endocrine monitoring. Further longitudinal studies are required to elucidate the long-term effects and underlying mechanisms of these alterations.
- 17 June 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (12) , 1536
Open AccessStructural and Hormonal Changes in Reproductive-Age Women Post-COVID-19: A Cross-Sectional Ultrasound and Biochemical Study
Background/Objectives: The long-term impact of COVID-19 on female reproductive health remains poorly understood. This study aimed to assess structural and endocrine alterations in women of reproductive age who had recovered from SARS-CoV-2 infection compared to uninfected controls. Materials and Methods: A total of 150 women aged 18–45 years were enrolled in a comparative study: 75 with a confirmed history of COVID-19 and 75 without one. All participants underwent ultrasound examinations of their pelvic organs and mammary glands, along with laboratory assessment of reproductive hormones and inflammatory markers. Results: Structural abnormalities in the pelvic organs were observed in 53.5% of the post-COVID-19 group versus 12.0% of the control group (p < 0.001), with oophoritis showing a statistically significant association (OR = 11.38; 95% CI: 1.42–91.36; p = 0.009). Non-significant but elevated frequencies were also found for uterine fibroids and breast cysts. Biochemically, post-COVID-19 participants demonstrated higher serum ferritin, estradiol, and fibrinogen levels, along with lower TSH and AMH levels, suggesting potential endocrine disruption and persistent inflammation. Conclusions: Women with a history of COVID-19 may be at increased risk of developing structural and hormonal abnormalities, highlighting the importance of post-infection gynecological and endocrine monitoring. Further longitudinal studies are required to elucidate the long-term effects and underlying mechanisms of these alterations.
- Open Access
- 13 May 2025
- Published by MDPI AG in Preprints.org
Structural and Hormonal Changes in Reproductive-Age Women Post-COVID-19: A Cross-Sectional Ultrasound and Biochemical Study
Background/Objectives: The long-term impact of COVID-19 on female reproductive health remains poorly understood. This study aimed to assess structural and endocrine alterations in women of reproductive age who had recovered from SARS-CoV-2 infection, compared to uninfected controls. Materials and Methods: A total of 150 women aged 18–45 years were enrolled in a comparative study: 75 with a confirmed history of COVID-19 and 75 without. All participants underwent ultrasound examinations of the pelvic organs and mammary glands, along with laboratory assessment of reproductive hormones and inflammatory markers. Statistical analysis was performed using the Mann–Whitney U-test and odds ratio calculations. Results: Structural abnormalities in the pelvic organs were observed in 53.5% of the post-COVID group versus 12.0% in the control group (p< 0.001), with oophoritis showing a statistically significant association (OR = 11.38; 95% CI: 1.42–91.36; p = 0.009). Non-significant but elevated frequencies were also found for uterine fibroids and breast cysts. Biochemically, post-COVID participants demonstrated higher serum ferritin, estradiol, and fibrinogen levels, along with lower TSH and AMH levels, suggesting potential endocrine disruption and persistent inflammation. Conclusions: Women with a history of COVID-19 may be at increased risk of developing structural and hormonal abnormalities, highlighting the importance of post-infection gynecological and endocrine monitoring. Further longitudinal studies are required to elucidate the long-term effects and underlying mechanisms of these alterations.
- 13 May 2025
- Published by MDPI AG in Preprints.org
Open AccessStructural and Hormonal Changes in Reproductive-Age Women Post-COVID-19: A Cross-Sectional Ultrasound and Biochemical Study
Background/Objectives: The long-term impact of COVID-19 on female reproductive health remains poorly understood. This study aimed to assess structural and endocrine alterations in women of reproductive age who had recovered from SARS-CoV-2 infection, compared to uninfected controls. Materials and Methods: A total of 150 women aged 18–45 years were enrolled in a comparative study: 75 with a confirmed history of COVID-19 and 75 without. All participants underwent ultrasound examinations of the pelvic organs and mammary glands, along with laboratory assessment of reproductive hormones and inflammatory markers. Statistical analysis was performed using the Mann–Whitney U-test and odds ratio calculations. Results: Structural abnormalities in the pelvic organs were observed in 53.5% of the post-COVID group versus 12.0% in the control group (p< 0.001), with oophoritis showing a statistically significant association (OR = 11.38; 95% CI: 1.42–91.36; p = 0.009). Non-significant but elevated frequencies were also found for uterine fibroids and breast cysts. Biochemically, post-COVID participants demonstrated higher serum ferritin, estradiol, and fibrinogen levels, along with lower TSH and AMH levels, suggesting potential endocrine disruption and persistent inflammation. Conclusions: Women with a history of COVID-19 may be at increased risk of developing structural and hormonal abnormalities, highlighting the importance of post-infection gynecological and endocrine monitoring. Further longitudinal studies are required to elucidate the long-term effects and underlying mechanisms of these alterations.
- Top Cited PapersOpen Access
The Multifactorial Pathogenesis of Endometriosis: A Narrative Review Integrating Hormonal, Immune, and Microbiome Aspects
Endometriosis (EM) is a common estrogen-dependent chronic inflammatory disorder affecting reproductive-aged women, yet its pathogenesis remains incompletely understood. Recent evidence suggests that the gut microbiota significantly influence immune responses, estrogen metabolism, and systemic inflammation, potentially contributing to EM progression. This narrative review explores the relationship between the gut microbiota and EM, emphasizing microbial dysbiosis, inflammation, estrogen regulation, and potential microbiome-targeted therapies. Studies published within the last 30 years were included, focusing on the microbiota composition, immune modulation, estrogen metabolism, and therapeutic interventions in EM. The selection criteria prioritized peer-reviewed articles, clinical trials, meta-analyses, and narrative reviews investigating the gut microbiota’s role in EM pathophysiology and treatment. Microbial dysbiosis in EM is characterized by a reduced abundance of beneficial bacteria (Lactobacillus, Bifidobacterium, and Ruminococcaceae) and an increased prevalence of pro-inflammatory taxa (Escherichia/Shigella, Streptococcus, and Bacteroides). The gut microbiota modulate estrogen metabolism via the estrobolome, contributing to increased systemic estrogen levels and lesion proliferation. Additionally, lipopolysaccharides (LPS) from Gram-negative bacteria activate the TLR4/NF-κB signaling pathway, exacerbating inflammation and EM symptoms. The interaction between the gut microbiota, immune dysregulation, and estrogen metabolism suggests a critical role in EM pathogenesis. While microbiota-targeted interventions offer potential therapeutic benefits, further large-scale, multi-center studies are needed to validate microbial biomarkers and optimize microbiome-based therapies for EM. Integrating microbiome research with precision medicine may enhance the diagnostic accuracy and improve the EM treatment efficacy.
Top Cited PapersOpen AccessThe Multifactorial Pathogenesis of Endometriosis: A Narrative Review Integrating Hormonal, Immune, and Microbiome Aspects
Endometriosis (EM) is a common estrogen-dependent chronic inflammatory disorder affecting reproductive-aged women, yet its pathogenesis remains incompletely understood. Recent evidence suggests that the gut microbiota significantly influence immune responses, estrogen metabolism, and systemic inflammation, potentially contributing to EM progression. This narrative review explores the relationship between the gut microbiota and EM, emphasizing microbial dysbiosis, inflammation, estrogen regulation, and potential microbiome-targeted therapies. Studies published within the last 30 years were included, focusing on the microbiota composition, immune modulation, estrogen metabolism, and therapeutic interventions in EM. The selection criteria prioritized peer-reviewed articles, clinical trials, meta-analyses, and narrative reviews investigating the gut microbiota’s role in EM pathophysiology and treatment. Microbial dysbiosis in EM is characterized by a reduced abundance of beneficial bacteria (Lactobacillus, Bifidobacterium, and Ruminococcaceae) and an increased prevalence of pro-inflammatory taxa (Escherichia/Shigella, Streptococcus, and Bacteroides). The gut microbiota modulate estrogen metabolism via the estrobolome, contributing to increased systemic estrogen levels and lesion proliferation. Additionally, lipopolysaccharides (LPS) from Gram-negative bacteria activate the TLR4/NF-κB signaling pathway, exacerbating inflammation and EM symptoms. The interaction between the gut microbiota, immune dysregulation, and estrogen metabolism suggests a critical role in EM pathogenesis. While microbiota-targeted interventions offer potential therapeutic benefits, further large-scale, multi-center studies are needed to validate microbial biomarkers and optimize microbiome-based therapies for EM. Integrating microbiome research with precision medicine may enhance the diagnostic accuracy and improve the EM treatment efficacy.
- Top Cited PapersOpen Access
Understanding the Burden and Management of Urinary Tract Infections in Women
Urinary tract infections (UTIs) represent a prevalent health concern among the female population, with anatomical and physiological determinants such as a shorter urethra and its proximity to the rectum augmenting vulnerability. The presence of Escherichia coli and various other pathogens plays a significant role in the etiology of these infections, which can be aggravated by sexual intercourse and disturbances to the vaginal microbiome. The physiological alterations associated with pregnancy further elevate the likelihood of UTIs, with untreated cases potentially leading to severe complications such as pyelonephritis, preterm labor, and stillbirth. Furthermore, postmenopausal women encounter an augmented risk of UTIs attributable to estrogen deficiency and vaginal atrophy, as well as conditions including pelvic organ prolapse (POP) and urinary incontinence (UI), which hinder optimal bladder functionality. The aforementioned factors, in conjunction with the rising prevalence of cesarean deliveries and catheterization, complicate the management of UTIs. While precise diagnosis is paramount, it remains a formidable challenge, notwithstanding advancements in molecular diagnostic techniques. Management strategies encompass antibiotic-sparing therapies; however, the increasing incidence of multidrug resistance represents an alarming trend. Diverse guidelines from various medical specialties endeavor to standardize treatment approaches, yet significant inconsistencies continue to exist. This study systematically appraises the extant guidelines, evaluating the quality of evidence while identifying areas of agreement and discord to supply practitioners with effective strategies for UTI management.
Top Cited PapersOpen AccessUnderstanding the Burden and Management of Urinary Tract Infections in Women
Urinary tract infections (UTIs) represent a prevalent health concern among the female population, with anatomical and physiological determinants such as a shorter urethra and its proximity to the rectum augmenting vulnerability. The presence of Escherichia coli and various other pathogens plays a significant role in the etiology of these infections, which can be aggravated by sexual intercourse and disturbances to the vaginal microbiome. The physiological alterations associated with pregnancy further elevate the likelihood of UTIs, with untreated cases potentially leading to severe complications such as pyelonephritis, preterm labor, and stillbirth. Furthermore, postmenopausal women encounter an augmented risk of UTIs attributable to estrogen deficiency and vaginal atrophy, as well as conditions including pelvic organ prolapse (POP) and urinary incontinence (UI), which hinder optimal bladder functionality. The aforementioned factors, in conjunction with the rising prevalence of cesarean deliveries and catheterization, complicate the management of UTIs. While precise diagnosis is paramount, it remains a formidable challenge, notwithstanding advancements in molecular diagnostic techniques. Management strategies encompass antibiotic-sparing therapies; however, the increasing incidence of multidrug resistance represents an alarming trend. Diverse guidelines from various medical specialties endeavor to standardize treatment approaches, yet significant inconsistencies continue to exist. This study systematically appraises the extant guidelines, evaluating the quality of evidence while identifying areas of agreement and discord to supply practitioners with effective strategies for UTI management.